The relative abundance of individual cellular mRNAs in the cytoplasm and on polysomes decreases between 2 and 6 hpi. by William J. Neidermyer Jr. (6866672)

Inhibition of GATA2 in clinical primary AML cells decreased the survival rate during chemo treatment. by Li Yang (6520)

Trends in mean age at diagnosis by exposure category, 1995–2019 (n = 2,621). by Katia Giguère (146393)

Trends in the proportion of patients with advanced stage of HIV infection (<200 CD4 cells/μL) at diagnosis among participants to the HIV-positive cohort at the <i>Clinique médicale... by Katia Giguère (146393)

Trends in the proportion of patients with late stage of HIV infection (<350 CD4 cells/μL) at diagnosis among participants to the HIV-positive cohort at the <i>Clinique médicale l’A... by Katia Giguère (146393)

(A-H). Case 1: primary subcutaneous facial alveolar echinococcosis. by Louis Bohard (22250661)

“…<b>(C-D)</b> FDG-PET scan sagittal images before the initiation of albendazole <b>(C)</b> and after 6 months <b>(D)</b>, with a significant decrease of the peri-metabolic activity (yellow circles). …”

A representative stress-strain curve of a 3D printed PCL/30% (wt.) nHAp scaffold obtained after compressive testing displaying the linear region to derive E () and the point pertai... by Zahra Yazdanpanah (10038944)

CPA treatment decreases cell death, Müller cell activation and microglial infiltration. by Manuel Soliño (5410001)

“…CPA treatment produced a significant decrease of GFAP expression when compared to CTL (13.02±10.67% vs control retinas 33.32±15.23%; unpaired Student´s t-test; p<0.01; n = 8). …”

Animation of a 3D reconstruction of an <i>ex vivo</i> acquired z-stack through the renal cortex of a BALB/cByJ SOPF mouse, 24h p.i. with wildtype <i>C</i>. <i>albicans</i>, express... by Fitz Gerald S. Silao (9384713)

HPV16 E1 decreases cell growth. by Fern Baedyananda (11888703)

MiR-148a does not affect LDLR and ABCA1 expression under lipid-deficient condition. by Na Wang (193263)

Subjects:

MiR-148a regulates (P)RR expression by targeting its 3’-UTR sequences. by Na Wang (193263)

Subjects:

MiR-148a reduces cellular LDL uptake by specifically modulating <i>(P)RR</i> expression. by Na Wang (193263)

Subjects:

Small interfering RNA targeting 3’-UTR regions of human LDLR effectively reduces luciferase activity. by Na Wang (193263)

Subjects:

MiR-148a reduces SORT1 protein abundance but does not affect its transcript levels. by Na Wang (193263)

Subjects:

MiR-148b regulates (P)RR expression by targeting its 3’-UTR sequences. by Na Wang (193263)

Subjects:

MiR-148a reduces cellular LDL uptake by reducing LDLR protein abundance but not its transcript levels. by Na Wang (193263)

Subjects:

Overexpressing (P)RR antagonizes miR-148a-induced reduction in cellular LDL uptake and LDLR protein abundance. by Na Wang (193263)

Subjects:

Glycogen phosphorylase knockdown decreases doubling time of MCF-7 and MCF-10A cells. by Megan A. Altemus (7405727)

“…<p>Glycogen phosphorylase knockdown decreases doubling time of MCF-7 and MCF-10A cells.…”

A summary of calibration standards (n = 3). by Ewa Paszkowska (21246702)

“…<div><p>Purpose</p><p>Statins are the most commonly used drugs worldwide. Besides a significant decrease in cardiovascular diseases (CVDs) risk, the use of statins is also connected with a broad beneficial pleiotropic effect. …”